Literature DB >> 7779052

Myocardial hibernation.

J D Schipke1.   

Abstract

From available results, the following schematic can be drawn: Reductions in perfusion pressure are not associated with impaired ventricular function as long as they take place within the autoregulatory range. Additional reductions in perfusion pressure that moderately diminish coronary blood flow will result in a particular ischemia with decreased but stable function: perfusion and contraction match, the myocardium hibernates. The process responsible for this new equilibrium could be termed down regulation of function. The trigger inducing hibernation is so far unknown. The strategy, however, is similar to that used by hibernating animals. Likewise, myocardial hibernation is a protective mechanism. As hibernators recover initial function after unfavourable periods are terminated, hibernating myocardium recovers after institution of physiologic perfusion. It is under debate, whether function quickly recovers or remains temporarily depressed. As hibernating animals might finally even die, if unfavourable periods last too long, myocardium might become irreversibly injured due to ischemia lasting too long. Additional reductions in perfusion pressure and oxygen supply below the hibernating range produce ischemia in the more classical sense, because oxygen supply and demand no longer match. Damage will become irreversible in case the situation persists longer than about 20 min. After onset of reperfusion, the myocardial function would remain depressed, however, for a considerable period: myocardial stunning. Considering the regional heterogeneities of myocardial blood flow, distinct differentiation between moderate and severe ischemia is difficult. Ischemia will induce more articulate damage in subendocardial than in subepicardial layers. Similarly, damage in the ischemic core will be more pronounced than in the border zone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7779052     DOI: 10.1007/bf00795112

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

Review 1.  Myocardial stunning and hibernation. The physiology behind the colloquialisms.

Authors:  E Marban
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

2.  Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium".

Authors:  E Braunwald; J D Rutherford
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

3.  Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease.

Authors:  M M Bodenheimer; V S Banka; G A Hermann; R G Trout; H Pasdar; R H Helfant
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

4.  Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia.

Authors:  G A Pantely; S A Malone; W S Rhen; C G Anselone; A Arai; J Bristow; J D Bristow
Journal:  Circ Res       Date:  1990-12       Impact factor: 17.367

5.  Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplasty.

Authors:  J P Melchior; P A Doriot; P Chatelain; B Meier; P Urban; L Finci; W Rutishauser
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

6.  Contractile failure and high-energy phosphate turnover during hypoxia: 31P-NMR surface coil studies in living rat.

Authors:  J A Bittl; J A Balschi; J S Ingwall
Journal:  Circ Res       Date:  1987-06       Impact factor: 17.367

7.  Improvement in rest and exercise-induced wall motion abnormalities after coronary angioplasty: an exercise echocardiographic study.

Authors:  T Broderick; S Sawada; W F Armstrong; T Ryan; J C Dillon; P D Bourdillon; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

8.  Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty.

Authors:  M Cohen; R Charney; R Hershman; V Fuster; R Gorlin
Journal:  J Am Coll Cardiol       Date:  1988-11       Impact factor: 24.094

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.